As both BRAF and KRAS mutations have been observed in the earliest identified colonic neoplasms, and recent papers have provided evidence that induction of the ras oncogenic pathway will result in DNA hypermethylation, a causative effect of BRAF/KRAS mutations is likely [24,46-50]. This evidence concerns the gene KRAS and colonic neoplasm.